Medscape Conference Coverage, based on selected sessions at the:
Society of Nuclear Medicine (SNM) 2008 Annual Meeting
June 14 - 18, 2008, New Orleans, Louisiana
This activity is not sanctioned by, nor a part of, the Society of Nuclear Medicine. Conference news does not receive grant support and is produced independently.
Conference News
Radioimmunotherapy Targets Metastatic Melanoma Lesions in Phase I TrialPromising findings from a phase I clinical trial indicate that melanin-binding monoclonal antibody labeled with rhenium-118 safely and effectively targets metastatic melanoma soft tissue lesions, investigators reported at the Society for Nuclear Medicine Annual meeting held in New Orleans.
CMEEstrogen May Be Neuroprotective After AllPositron emission tomographic scans show benefit in continuing estrogen long term in postmenopausal women at risk for Alzheimer's disease.
Medscape Medical News, June 18, 2008
PET Plays a Role in Radioimmunotherapy for NHLFDG-PET has been shown to be a valuable tool for selecting candidates for treatment with yttrium 90 ibritumomab tiuxetan in some patients with non-Hodgkin's lymphoma who have relapsed on standard chemotherapy.
Rapid SPECT Cuts Cardiac Imaging Time in HalfA new means of performing gated SPECT myocardial perfusion produces data in half the usual acquisition time, with no sacrifice in image quality.
The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the Society of Nuclear Medicine. These materials and the related activity are not sanctioned by the Society of Nuclear Medicine or the commercial supporter of the conference and do not constitute an official part of that conference.
